Dr Song Li

Dr. Song Li is the Director-General, Deparment of Women & Child Health of the National Health Commission of the People's Republic of China. She has been engaged in women and children's health administration for 21 years.

Since 2002, she has either participated in or been in charge of organizing and formulating a series of important women and children health-related laws and regulations and policy documents and organized the development and revision of women and child health-related policy documents such as midwifery technology, prenatal diagnosis, and assisted reproductive technology, as well as related supervision and management.

She organized and launched a number of major women and children health projects deepening the reform of the medical and health system and a number of international cooperation projects, such as a project to ensure maternal and child safety, cervical cancer and breast cancer screening project for rural women, hospital-based delivery subsidies project for rural women, folic acid supplementation project to prevent neural tube defects, prevent mother-to-child transmission of HIV/AIDS, syphilis, hepatitis B project, and adolescent health and development project and other major projects. In 2022, she was awarded the Women's Merit Model for distinguished service to women’s health by All-China Women's Federation (ACWF).

 Dr. Song Li is a current member of the Mother and Newborn Information for Tracking Outcomes and Results (MoNITOR) Advisory Group (AG) of WHO. From Apr. 2020 to Mar. 2023, she was a WHO STAGE member for Maternal Newborn Child Adolescent Health & Nutrition. She is Co-Chair of the Lancet RMNCAH Commission on Women’s Reproductive, Maternal, Newborn, Child, and Adolescent Health (RMNCAH) in China.

Dr. Song Li was trained in Clinical Medicine, Master of Obstetrics and Gynecology at Shandong Medical University, then in public health with a Ph.D from Peking University, and later received training in Global Health as a visiting scholar at Harvard University.